Showing results (1931-1940 of 2,369) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|March 31, 2022
Citrate transporter inhibitors: possible new anticancer agentsShivaputra A Patil, June A Mayor, Ronald S Kaplan
Future Medicinal Chemistry|August 9, 2018
Synthesis of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines as antimicrobial agents with potential inhibition of DHPS enzymeMaryam A Z El-Attar, Rasha Y Elbayaa, Omaima G Shaaban, et al.
Future Medicinal Chemistry|August 10, 2018
Hypoxia-inducible factor 2α: a novel target in gliomasJaclyn J Renfrow, Michael H Soike, Waldemar Debinski, et al.
Future Medicinal Chemistry|July 26, 2018
Make azoles active again: chalcones as potent reversal agents of transporters-mediated resistance in Candida albicansShweta Nim, Pratima Baghel, Viet-Khoa Tran-Nguyen, et al.
Future Medicinal Chemistry|February 18, 2010
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disordersEric Mills, Xian-Ping Dong, Fudi Wang, et al.
Future Medicinal Chemistry|August 31, 2016
On the origins of three-dimensionality in drug-like moleculesJoshua Meyers, Michael Carter, N Yi Mok, et al.
Future Medicinal Chemistry|August 31, 2016
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseasesAlokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, et al.
Future Medicinal Chemistry|August 31, 2016
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)Dmytro Ostrovskyi, Tobias Rumpf, Julia Eib, et al.
Future Medicinal Chemistry|September 1, 2016
3D-Lab: a collaborative web-based platform for molecular modelingChristoph Grebner, Magnus Norrby, Jonatan Enström, et al.
Future Medicinal Chemistry|May 13, 2017
Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegenerationEva Ramos, Javier Egea, Cristóbal de Los Ríos, et al.
Pageof 237